 | Up a level |
Journal Article
Ackermann, S., Cartolano, M., Hero, B., Roderwieser, A., Bartenhagen, C., Rosswog, C., Hertwig, F., Simon, T., Eggert, A., Speleman, F., Buettner, R., O'Sullivan, R., Thomas, R., Berthold, F., Vandesompele, J., Schramm, A., Westermann, F., Schulte, J., Peifer, M. and Fischer, M. (2018). A Mechanistic Classification of Clinical Phenotypes in Neuroblastoma. Pediatr. Blood Cancer, 65. S. S87 - 2. HOBOKEN: WILEY. ISSN 1545-5017
Ackermann, S., Cartolano, M., Hero, B., Roderwieser, A., Bartenhagen, C., Rosswog, C., Hertwig, F., Simon, T., Eggert, A., Speleman, F., Buettner, R., O'sullivan, R., Thomas, R., Berthold, F., Vandesompele, J., Schramm, A., Westermann, F., Schulte, J., Peifer, M. and Fischer, M. (2018). A Mechanistic Classification of Clinical Phenotypes in Neuroblastoma. Pediatr. Blood Cancer, 65. S. S234 - 1. HOBOKEN: WILEY. ISSN 1545-5017
Deubzer, H., Fabian, J., Opitz, D., Althoff, K., Lodrini, M., Astrahantseff, K., Hero, B., Volland, R., Beckers, A., De Preter, K., Patil, N., Abba, M., Wuenchel, J., Thole, T., Hu, J., Schweitzer, L., Mechtersheimer, G., Carter, D., Cheung, B., Popanda, O., von Deimling, A., Henrich, K. O., Westermann, F., Schwab, M., Koster, J., Versteeg, R., Marshall, G., Speleman, F., Zoeller, M., Allgayer, H., Fischer, M., Berthold, F., Kulozik, A., Witt, O., Schulte, J. and Eggert, A. (2015). MYCN TRANSCRIPTIONALLY REPRESSES CD9 TO TRIGGER AN INVASION-METASTASIS CASCADE IN NEUROBLASTOMA. Pediatr. Blood Cancer, 62. S. S150 - 1. HOBOKEN: WILEY-BLACKWELL. ISSN 1545-5017
Eggert, A., Schramm, A., Koester, J., Assenov, Y., Kristina, A., Engesser, A., Kahlert, Y., Theissen, J., Hero, B., Roels, F., Peifer, M., Astrahantseff, K., Depreter, K., Lode, H., Speleman, F., Schmezer, P., Westermann, F., Rahmann, S., Fischer, M. and Schulte, J. (2015). INTEGRATED GENOMIC ANALYSIS IDENTIFIES SPECIFIC ALTERATIONS AND ACTIVATION OF YAP IN RELAPSED NEUROBLASTOMA. Pediatr. Blood Cancer, 62. S. S145 - 1. HOBOKEN: WILEY-BLACKWELL. ISSN 1545-5017
Fischer, M., Wulff, B., Baruchel, S., Berlanga, P., Trahair, T., Mechinaud, F., Schulte, J., Modak, S., Merks, J. H., Zwaan, C. M., Marshall, L. V., Casanova, M., Branle, F., Malet, I., Emeremni, A. C. and Geoerger, B. (2016). Phase 1 study of ceritinib in pediatric patients with malignancies harboring activated anaplastic lymphoma kinase (ALK): Safety, pharmacokinetics and efficacy results from the fed population. Eur. J. Cancer, 69. S. S49 - 2. OXFORD: ELSEVIER SCI LTD. ISSN 1879-0852
Rosswog, C., Fassunke, J., Schoemig-Markiefka, B., Merkelbach-Bruse, S., Ackermann, S., Ortmann, M., Schulte, J., Westermann, F., Berthold, F., Simon, T., Hero, B. and Fischer, M. (2020). ALK Mutations in Primary and Relapsed Neuroblastoma in a GPOH Cohort. Pediatr. Blood Cancer, 67. S. S57 - 2. HOBOKEN: WILEY. ISSN 1545-5017
Schulte, J., Schramm, A., Koester, J., Westermann, F., Peifer, M., Fischer, M., Rahmann, S. and Eggert, A. (2016). Mutational dynamics between primary and relapse neuroblastoma involve genes relevant for mesenchymal transition. Oncol. Res. Treat., 39. S. 30 - 32. BASEL: KARGER. ISSN 2296-5262